Prognostic relevance of ARFI elastography in comparison to liver histology and the FIB-4 score

被引:0
|
作者
Klueppel, Moritz [1 ]
Adler, Werner [2 ]
Schellhaas, Barbara [1 ]
Jesper, Daniel [1 ]
Neurath, Markus F. [1 ,3 ]
Pfeifer, Lukas [4 ]
机构
[1] Erlangen Univ Hosp, Dept Internal Med 1, Dept Med Gastroenterol Endocrinol & Pneumol 1, Ulmenweg 18, D-91054 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nuremberg, Dept Med Informat Biometry & Epidemiol, Erlangen, Germany
[3] Erlangen Univ Hosp, German Ctr Immunotherapy DZI, Erlangen, Germany
[4] Krankenhaus Barmherzige Bruder Regensburg, Dept Gastroenterol & Intervent Endoscopy, Regensburg, Germany
来源
关键词
ARFI elastography; liver fibrosis; liver cirrhosis; FIB-4; Score; liver histology; NONINVASIVE TESTS; FIBROSIS; DIAGNOSIS; BIOPSY; ULTRASOUND; INDEX;
D O I
10.1055/a-2178-4808
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Purpose Liver histology has prognostic relevance and is used in surveillance and therapeutic strategies. This longitudinal study was designed to evaluate the prognostic relevance of ARFI elastography in comparison to liver histology and to the FIB-4 score in a 5-year observation interval. Materials and Methods Based on the hospital database, patients with an elastography examination of the liver between 2010-2012, a liver biopsy, and a follow-up of 5 years were included in the study. The AUROCs of the events liver-related death, HCC, and liver decompensation/variceal bleeding were calculated for ARFI elastography, liver histology, and FIB-4 and compared using the DeLong test. Results In the final analysis 113 patients were included with 30 (26.5 %) patients having high-grade fibrosis and 19 (16.8 %) having liver cirrhosis in histology. The AUROC for liver-related death in the 5-year interval (9.7 %, n=11) was 0.80 [0.68-0.92] for ARFI elastography, 0.79 [0.66-0.92] for liver histology, and 0.66 [0.53-0.79] for FIB-4 with a p-value of 0.83 comparing ARFI to histology and a p-value of 0.02 comparing ARFI to FIB-4. The AUROC for liver decompensation/variceal bleeding (13.3 %, n=15) was 0.86 [0.76-0.94] for ARFI, which is significantly higher than the AUROC of liver histology with 0.71 [0.56-0.86] (p=0.02) and FIB-4 with 0.67 [0.54-0.80] (p=0.003). There was no significant difference for the event HCC when comparing ARFI to histology (p=0.33) or FIB-4 (p=0.14). Conclusion The prognostic value of ARFI elastography seems to not be inferior to liver histology regarding liver-related survival and might even outperform histology and the FIB-4 score for predicting some liver-related complications.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease
    Maryam Moini
    Fernanda Onofrio
    Bettina E. Hansen
    Oyedele Adeyi
    Korosh Khalili
    Keyur Patel
    Scientific Reports, 11
  • [22] PROGNOSTIC VALUE OF LIVER STIFFNESS AND FIB-4 SCORE IN INDIVIDUALS WITH CIRRHOSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT PREVIOUS LIVER DECOMPENSATION
    Abdulle, A.
    Armandi, A.
    Caviglia, G. P.
    Rosso, C.
    D'Amato, D.
    Castelnuovo, G.
    Del Campo, Perez Diaz N.
    Gjini, K.
    Poggiolini, I
    Guariglia, M.
    Saracco, G. M.
    Bugianesi, E.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S165 - S166
  • [23] SCREENING FOR HEPATIC FIBROSIS IN GENERAL PRACTICE BY FIB-4 SCORE, FOLLOWED IN SECOND LINE BY THE ELF (ENHANCED LIVER FIBROSIS) TEST: WHICH FIB-4 THRESHOLDS TO CHOOSE?
    Ouzan, Denis
    Penaranda, Guillaume
    Bournot, Franck
    Corneille, Jeremie
    HEPATOLOGY, 2022, 76 : S1051 - S1051
  • [24] Evaluation of Fibrosis in Serial Liver Biopsies of Nonalcoholic Fatty Liver Disease: Is FIB-4 Score as Good as Liver Biopsy?
    Putra, J.
    Glass, L. M.
    Toor, A.
    Suriawinata, A. A.
    MODERN PATHOLOGY, 2014, 27 : 427A - 427A
  • [25] Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
    Kjaergaard, Maria
    Lindvig, Katrine Prier
    Thorhauge, Katrine Holtz
    Andersen, Peter
    Hansen, Johanne Kragh
    Kastrup, Nanna
    Jensen, Jane Moller
    Hansen, Camilla Dalby
    Johansen, Stine
    Israelsen, Mads
    Torp, Nikolaj
    Trelle, Morten Beck
    Shan, Shan
    Detlefsen, Soenke
    Antonsen, Steen
    Anderson, Jorgen Ellegaard
    Graupera, Isabel
    Gines, Pere
    Thiele, Maja
    Krag, Aleksander
    JOURNAL OF HEPATOLOGY, 2023, 79 (02) : 277 - 286
  • [26] Combined use of the CLivD score and FIB-4 for prediction of liver-related outcomes in the population
    Aberg, Fredrik
    Asteljoki, Juho
    Maennistoe, Ville
    Luukkonen, Panu K.
    HEPATOLOGY, 2024, 80 (01) : 163 - 172
  • [27] FIB-4 score association with operative outcomes, truth or fibs?
    Stretton, Brandon
    Kovoor, Joshua
    Tse, Edmund
    Maddern, Guy
    Bacchi, Stephen
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 132 : 139 - 141
  • [28] Evaluation of Fibrosis in Serial Liver Biopsies of Nonalcoholic Fatty Liver Disease: Is FIB-4 Score as Good as Liver Biopsy?
    Putra, J.
    Glass, L. M.
    Toor, A.
    Suriawinata, A. A.
    LABORATORY INVESTIGATION, 2014, 94 : 427A - 427A
  • [29] An Elevated FIB-4 Score is associated with the severity of heart failure
    Bielecka-Dabrowa, A.
    Sakowicz, A.
    Banach, M.
    Slot, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] Superior prognostic accuracy of the LiverPRO score versus FIB-4 in predicting liver-related events in a cohort of 457, 152 individuals
    Lindvig, Katrine
    Moller, Soren
    Thorhauge, Katrine
    Hansen, Johanne Kragh
    Hansen, Camilla Dalby
    Johansen, Stine
    Schnefeld, Helle
    Israelsen, Mads
    Andersen, Peter
    Villesen, Ida Falk
    Bech, Katrine Tholstrup
    Torp, Nikolaj
    Krag, Aleksander
    Thiele, Maja
    JOURNAL OF HEPATOLOGY, 2024, 80 : S205 - S206